newsfilter
← Latest News
CNBC·

Nestle pays $2 billion to secure Aimmune's allergy treatment

Nestle plans to pay $2 billion to gain full ownership of peanut allergy treatment maker Aimmune Therapeutics, as the Swiss company expands its fast-growing health science business.